College ter Beoordeling van Geneesmiddelen | Medicines Evaluation Board The MEB is the official Dutch authority responsible for assessing the efficacy and safety of medicines that apply for admission to the market. Our work involves medicines available in the Netherlands and - together with our European colleagues - medicines available across Europe, from traditional to entirely new medicines. Company activities: The MEB is responsible for medicine marketing authorisations in accordance with the Medicines Act. We assess the balance between the efficacy and the adverse reactions and risks of medicines. We also examine whether the quality of the medicine is satisfactory and remains so. An opinion by the MEB may, for example, relate to new marketing authorisations for medicines, the amendment, suspension or withdrawal of these marketing authorisations, but also pharmacovigilance and patient information leaflets. We frequently carry out our tasks on the basis of collaboration in the Netherlands and with other national authorities in Europe. We are looking for Specialists in regulatory affairs, pharmacists with in-depth knowledge regarding drug quality (think composition but also, for example, production processes) and clinical specialists who know from experience what a drug can cause in a patient's body. What we have to offer A top class scientific work environment with the chance to be among the first to become familiar with innovative - and sometimes revolutionary - products and techniques in the field of medicine.